RxDoctor Payments Data

Mark Siegel, MD

Dermatology · Charleston, SCNPI 1437536463

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Arcutis Biotherapeutics, Inc. at 37.4% of the total. 2025 is the largest year on record at $87,359, more than ten times the $413 reported in 2019. Among dermatology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$120,259in general payments, 2019–2025

Across 330 payments — averaging $364.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$45K
  • Sanofi$44K
  • Regeneron Healthcare Solutions, Inc.$17K
  • Pierre Fabre Pharmaceuticals, Inc.$5K
  • Incyte Corporation$3K
  • Dermavant Sciences, Inc.$2K
  • plus $5K from 26 others

What the payments were for

  • Consulting fees$54,82846%
  • Speaking & faculty fees$38,99632%
  • Travel & lodging$13,80411%
  • Food & beverage$12,35910%
  • Education$2720%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$120,259 in reported general payments places this provider in the 95th percentile of 203 dermatology providers in South Carolina.

See all dermatology providers in South Carolina

Medicare billing

Part B allowed, 2024
$121,805
Medicare patients
297
Services billed
1,962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate33$1,248
Fluorouracil16$1,108
Tacrolimus13$1,039
Ketoconazole35$581
Triamcinolone Acetonide39$484
Mupirocin39$360
Clindamycin Phosphate11$339
Doxycycline Hyclate19$179
Mometasone Furoate13$143
Hydrocortisone19$73

Paid to pharmacies, not to this prescriber.

Other dermatology in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →